文献速递妇科产科

血浆游离RNA机器学习模型用于术前区分子宫平滑肌肉瘤与平滑肌瘤

Liquid biopsy cell-free RNA-based machine learning enables preoperative risk-stratification of uterine leiomyosarcoma.
PubMed 文献 · Am J Obstet Gynecol · 2026-07-24

这项前瞻性多中心研究纳入16家西班牙医院102例疑似子宫肌层肿瘤手术患者,利用血浆游离RNA的100基因特征建立逻辑回归分类器,在术前区分子宫平滑肌肉瘤与平滑肌瘤,交叉验证AUC为0.868,外部组织队列AUC为0.892,提示其有望辅助术前风险分层。

要点

  • 100基因血浆cfRNA分类器术前区分平滑肌肉瘤与平滑肌瘤AUC为0.868
  • 敏感度0.732、特异度0.813,55岁以下与以上AUC分别为0.879与0.882
  • 外部组织队列AUC为0.892,支持生物学可推广性,但尚非成熟诊断试验

核心结论

  • 血浆游离RNA信号在子宫平滑肌肉瘤与平滑肌瘤之间存在差异,经前瞻性验证后可能有助于术前风险分层。
  • 该研究尚未确立准确的诊断试验,阳性预测值取决于应用人群的患病率。

研究设计与样本

  • 前瞻性多中心研究,在西班牙16家医院纳入因疑似子宫肌层肿瘤接受手术的女性。
  • 术前采集外周血,术后组织病理为参考标准,最终队列102例(平滑肌瘤78例,平滑肌肉瘤24例)。
  • 利用血浆游离RNA谱训练和评估包含100基因特征的模型,评估AUC、敏感度、特异度、阳性预测值和阴性预测值。

主要发现

  • 100基因血浆游离RNA特征可在术前区分子宫平滑肌瘤与平滑肌肉瘤。
  • 正则化逻辑回归分类器在蒙特卡洛交叉验证中AUC为0.868,敏感度0.732,特异度0.813。
  • 诊断性能在各年龄组保持一致,55岁以下女性AUC为0.879,55岁以上女性AUC为0.882。
  • 在独立外部组织队列中,基因特征保持较强区分能力,AUC为0.892。

关键数值与推荐

  • 100基因特征组合的正则化逻辑回归分类器AUC为0.868,敏感度0.732,特异度0.813(蒙特卡洛交叉验证)。
  • 55岁以下女性AUC为0.879,55岁以上女性AUC为0.882。
  • 独立外部组织队列AUC为0.892。

临床怎么用

  • 目前证据尚不足以将血浆cfRNA检测作为确诊工具,临床决策仍需依据病理。
  • 在适当选择的人群中完成前瞻性验证后,该检测可能辅助术前风险分层,减少意外恶性播散风险。
  • 解读阳性预测值时需考虑应用人群的平滑肌肉瘤患病率。

局限性

  • 作者指出这些为初步发现,尚未建立准确的诊断试验。
  • 阳性预测值将取决于检测应用人群的患病率。
  • 研究纳入的平滑肌肉瘤病例数为24例,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accurate preoperative distinction between uterine leiomyoma and uterine leiomyosarcoma remains a major clinical challenge. Misclassification can lead to inadvertent dissemination of occult malignancy during minimally invasive procedures, while cautious management increases the use of more invasive surgery with greater morbidity. Current diagnostic approaches, including imaging and serum biomarkers, lack sufficient accuracy and standardized criteria. Circulating cell-free RNA in plasma represents a promising alternative for noninvasive tumor classification, but its clinical utility for uterine leiomyosarcoma has not been established. OBJECTIVE: To develop a plasma-based circulating cell-free RNA machine learning classifier for the preoperative differentiation of uterine leiomyosarcoma from uterine leiomyoma, and to evaluate its diagnostic performance and biological generalizability. STUDY DESIGN: This prospective, multicenter study enrolled women undergoing surgery for suspected myometrial tumors at 16 hospitals in Spain. Peripheral blood was collected immediately before surgery, and postoperative histopathology served as the reference standard. The final cohort included 102 patients (78 uterine leiomyoma; 24 uterine leiomyosarcoma). Plasma cell-free RNA profiles were used to train and evaluate a model consisting of a 100-gene signature. Diagnostic performance was assessed using area under the receiver operating characteristic curve, sensitivity, specificity, positive predictive value, and negative predictive value. Age effects and cross-tissue generalizability were also evaluated. RESULTS: A 100-gene circulating cell-free RNA signature reliably differentiates uterine leiomyoma from uterine leiomyosarcoma before surgery. This regularized logistic regression classifier achieved an area under the receiver operating characteristic curve of 0.868, with a sensitivity of 0.732, and a specificity of 0.813 in Monte Carlo cross-validation. Diagnostic performance remained consistent across age groups, with an area under the receiver operating characteristic curve of 0.879 for women below 55 years of age and 0.882 for women above 55 years. Notably, when evaluated in an independent external tissue cohort, the gene signature retained strong discriminatory performance, achieving an area under the receiver operating characteristic curve of 0.892, supporting its biological and translational robustness. CONCLUSION: These preliminary findings suggest that plasma cell-free RNA signals differ between uterine leiomyosarcoma and uterine leiomyoma and may, after prospective validation in appropriately selected populations, contribute to preoperative risk stratification. They do not yet establish an accurate diagnostic test, and positive predictive value will depend on the prevalence of the population in which the assay is applied.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Stahlschmidt SR, Lago V, Machado-López A, et al. Liquid biopsy cell-free RNA-based machine learning enables preoperative risk-stratification of uterine leiomyosarcoma. Am J Obstet Gynecol. 2026. PMID: 42492601. doi:10.1016/j.ajog.2026.07.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。